Stuart A. Arbuckle - 21 Jun 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Director
Signature
/s/ Hunter Smith, attorney-in-fact for Stuart A. Arbuckle
Issuer symbol
RYTM
Transactions as of
21 Jun 2024
Net transactions value
$0
Form type
4
Filing time
25 Jun 2024, 16:41:15 UTC
Previous filing
20 Jun 2024
Next filing
06 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +3,000 3,000 21 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -3,000 -100% $0.000000* 0 21 Jun 2024 Common Stock 3,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date.